PH12014501796A1 - Methods and composition related to brown adipose-like cells - Google Patents
Methods and composition related to brown adipose-like cellsInfo
- Publication number
- PH12014501796A1 PH12014501796A1 PH12014501796A PH12014501796A PH12014501796A1 PH 12014501796 A1 PH12014501796 A1 PH 12014501796A1 PH 12014501796 A PH12014501796 A PH 12014501796A PH 12014501796 A PH12014501796 A PH 12014501796A PH 12014501796 A1 PH12014501796 A1 PH 12014501796A1
- Authority
- PH
- Philippines
- Prior art keywords
- cells
- brown adipose
- artery
- derived
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261599080P | 2012-02-15 | 2012-02-15 | |
| PCT/US2013/026170 WO2013123214A1 (en) | 2012-02-15 | 2013-02-14 | Methods and composition related to brown adipose-like cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12014501796A1 true PH12014501796A1 (en) | 2014-11-24 |
Family
ID=47757703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12014501796A PH12014501796A1 (en) | 2012-02-15 | 2014-08-08 | Methods and composition related to brown adipose-like cells |
Country Status (16)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10335437B2 (en) | 2012-08-10 | 2019-07-02 | The Trustees Of Columbia University In The City Of New York | Injectable brown adipose microtissues for treatment and prevention of obesity and diabetes |
| ES2859548T3 (es) * | 2013-04-19 | 2021-10-04 | Biorestorative Therapies Inc | Células madre derivadas de tejido adiposo marrón humano y sus usos |
| US10092738B2 (en) * | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
| CN108350423A (zh) * | 2015-07-10 | 2018-07-31 | 法国血液机构 | 用于获得人类褐色/米色脂肪细胞的方法 |
| CN115433707A (zh) * | 2015-12-07 | 2022-12-06 | 再生疗法有限公司 | 用于重新衍生不同的多能干细胞衍生的褐色脂肪细胞的方法 |
| US20210077536A1 (en) | 2019-04-29 | 2021-03-18 | Biorestorative Therapies, Inc. | Non-naturally occuring three-dimensional (3d) brown adipose-derived stem cell aggregates, and methods of generating and using the same |
| CN110484566B (zh) * | 2019-08-29 | 2021-06-29 | 中国人民解放军第四军医大学 | 一种类棕色脂肪外泌体及其工程化生产方法和应用 |
| EP4083194A4 (en) * | 2019-11-25 | 2024-01-03 | Kataoka Corporation | COMPOSITION FOR MEDIUM |
| CN113493764B (zh) * | 2021-07-27 | 2023-01-24 | 新乡医学院 | 一种体外诱导小鼠耳朵间充质干细胞分化为脂肪细胞的方法 |
| CN114225006B (zh) * | 2021-12-22 | 2023-10-13 | 南京市妇幼保健院 | 一种棕色脂肪细胞分泌肽在低体温疾病防治中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100150885A1 (en) * | 2005-06-01 | 2010-06-17 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
| CA2725208A1 (en) * | 2008-05-06 | 2009-11-12 | Joslin Diabetes Center, Inc. | Methods and compositions for inducing brown adipogenesis |
| CA2763548C (en) * | 2008-05-27 | 2019-01-15 | Energesis Pharmaceuticals, Inc. | Brown adipocyte progenitors in human skeletal muscle |
| US8323972B2 (en) * | 2009-09-30 | 2012-12-04 | Advanced Technologies And Regenerative Medicine, Llc | Mammary artery derived cells and methods of use in tissue repair and regeneration |
-
2013
- 2013-02-12 US US13/765,008 patent/US20130209418A1/en not_active Abandoned
- 2013-02-14 JP JP2014557772A patent/JP2015508654A/ja active Pending
- 2013-02-14 HK HK15105657.6A patent/HK1205185A1/xx unknown
- 2013-02-14 BR BR112014020229A patent/BR112014020229A8/pt not_active IP Right Cessation
- 2013-02-14 IN IN6603DEN2014 patent/IN2014DN06603A/en unknown
- 2013-02-14 RU RU2014137102A patent/RU2014137102A/ru not_active Application Discontinuation
- 2013-02-14 WO PCT/US2013/026170 patent/WO2013123214A1/en active Application Filing
- 2013-02-14 EP EP13707083.5A patent/EP2814949A1/en not_active Withdrawn
- 2013-02-14 KR KR20147025501A patent/KR20140133574A/ko not_active Withdrawn
- 2013-02-14 MX MX2014009837A patent/MX2014009837A/es not_active Application Discontinuation
- 2013-02-14 CN CN201380009655.9A patent/CN104114693A/zh active Pending
- 2013-02-14 SG SG11201404763XA patent/SG11201404763XA/en unknown
- 2013-02-14 AU AU2013221474A patent/AU2013221474A1/en not_active Abandoned
- 2013-02-14 CA CA2864103A patent/CA2864103A1/en not_active Abandoned
-
2014
- 2014-08-08 PH PH12014501796A patent/PH12014501796A1/en unknown
- 2014-09-12 ZA ZA2014/06726A patent/ZA201406726B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2814949A1 (en) | 2014-12-24 |
| RU2014137102A (ru) | 2016-04-10 |
| KR20140133574A (ko) | 2014-11-19 |
| CN104114693A (zh) | 2014-10-22 |
| MX2014009837A (es) | 2014-09-16 |
| JP2015508654A (ja) | 2015-03-23 |
| ZA201406726B (en) | 2016-05-25 |
| BR112014020229A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2017-06-20 |
| BR112014020229A8 (pt) | 2017-07-11 |
| CA2864103A1 (en) | 2013-08-22 |
| HK1205185A1 (en) | 2015-12-11 |
| SG11201404763XA (en) | 2014-10-30 |
| AU2013221474A1 (en) | 2014-09-25 |
| US20130209418A1 (en) | 2013-08-15 |
| IN2014DN06603A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-05-22 |
| WO2013123214A1 (en) | 2013-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501796A1 (en) | Methods and composition related to brown adipose-like cells | |
| ZA202106265B (en) | Compositions and methods for inhibiting gene expression of lpa | |
| NZ599830A (en) | Novel kinase modulators | |
| MY200087A (en) | Rnai agents and compositions for inhibiting expression of angiopoietin-like 3 (angptl3), and methods of use | |
| MY160349A (en) | Pyridone and aza-pyridone compounds and methods of use | |
| EP2555627A4 (en) | METHOD FOR TREATING CARCINOMA | |
| WO2012058673A3 (en) | Enhanced cancer treatment and monitoring using recombinant vectors | |
| PH12013500389A1 (en) | Differentiation of human embryonic stem cells | |
| WO2012000103A8 (en) | Methods of targeting pten mutant diseases and compositions therefor | |
| MX2014005282A (es) | Compuestos de 8-fluoroftalazin-1 (2h) -ona. | |
| MX2015000428A (es) | Composiciones y metodos para regular celulas t car. | |
| NZ608734A (en) | Bone marrow derived cd271 precursor cells for cardiac repair | |
| PH12014501429A1 (en) | Differentiation of human embryonic stem cells into single hormonal insulin positive cells | |
| PH12014500966A1 (en) | Alkylated piperazine compounds as inhibitors of btk activity | |
| PH12014500936A1 (en) | Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity | |
| PH12013500367A1 (en) | Differentiation of human embryonic stem cells | |
| MX365365B (es) | Induccion de gen de trail de molécula pequeña en células normales y tumorales como una terapia anticáncer. | |
| PH12013501688A1 (en) | Treatment of amyotrophic lateral sclerosis using umbilical derived cells | |
| WO2013149211A3 (en) | Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation | |
| WO2012092049A3 (en) | Brown adipocyte modification | |
| WO2013124815A3 (en) | Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof | |
| HK1197276A1 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
| MX2019007057A (es) | Composiciones de adenovirus. | |
| EP2703481A4 (en) | BROWN ADIPOCYTES OBTAINED FROM PLURIPOTENTIAL STEM CELLS, CELL AGGRAIN OBTAINED FROM PLURIPOTENTIAL STEM CELLS, METHOD OF MANUFACTURE THEREOF, AND CELL THERAPY AND MEDICAL THERAPY THEREFOR | |
| WO2010104796A3 (en) | Methods of modulating smooth muscle cell proliferation and differentiation |